Relationship of Serum GDF11 Levels with Bone Mineral Density and Bone Turnover Markers in Postmenopausal Chinese Women

Overview

Journal Bone Res

Specialties Endocrinology
Orthopedics

Date 2016 Jul 14

PMID 27408764

Citations 9

Authors

Yusi Chen

Qi Guo

Min Zhang

Shumin Song

Tonggui Quan

Tiepeng Zhao

Hongliang Li

Lijuan Guo

Tiejian Jiang

Guangwei Wang

Affiliations

Soon will be listed here.

Abstract

Growth differentiation factor 11 (GDF11) is an important circulating factor that regulates aging. However, the role of GDF11 in bone metabolism remains unclear. The present study was undertaken to investigate the relationship between serum GDF11 level, bone mass, and bone turnover markers in postmenopausal Chinese women. Serum GDF11 level, bone turnover biochemical markers, and bone mineral density (BMD) were determined in 169 postmenopausal Chinese women (47-78 years old). GDF11 serum levels increased with aging. There were negative correlations between GDF11 and BMD at the various skeletal sites. After adjusting for age and body mass index (BMI), the correlations remained statistically significant. In the multiple linear stepwise regression analysis, age or years since menopause, BMI, GDF11, and estradiol were independent predictors of BMD. A significant negative correlation between GDF11 and bone alkaline phosphatase (BAP) was identified and remained significant after adjusting for age and BMI. No significant correlation was noted between cross-linked N-telopeptides of type I collagen (NTX) and GDF11. In conclusion, GDF11 is an independent negative predictor of BMD and correlates with a biomarker of bone formation, BAP, in postmenopausal Chinese women. GDF11 potentially exerts a negative effect on bone mass by regulating bone formation.

Citing Articles

Myokines: metabolic regulation in obesity and type 2 diabetes.

Chen Z, Weng Z, Lin J, Meng Z Life Metab. 2025; 3(3):loae006.

PMID: 39872377 PMC: 11749576. DOI: 10.1093/lifemeta/loae006.

Novel insights into the pleiotropic health effects of growth differentiation factor 11 gained from genome-wide association studies in population biobanks.

Strosahl J, Ye K, Pazdro R BMC Genomics. 2024; 25(1):837.

PMID: 39237910 PMC: 11378601. DOI: 10.1186/s12864-024-10710-7.

Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice.

Weidner H, Wobus M, Hofbauer L, Rauner M, Platzbecker U Leukemia. 2022; 36(11):2715-2718.

PMID: 36175549 PMC: 9613459. DOI: 10.1038/s41375-022-01702-1.

Growth differentiation factor-11 downregulates steroidogenic acute regulatory protein expression through ALK5-mediated SMAD3 signaling pathway in human granulosa-lutein cells.

Jia Q, Liu B, Dang X, Guo Y, Han X, Song T Reprod Biol Endocrinol. 2022; 20(1):34.

PMID: 35183204 PMC: 8857810. DOI: 10.1186/s12958-022-00912-7.

Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs.

Rodgers B, Ward C Endocr Rev. 2021; 43(2):329-365.

PMID: 34520530 PMC: 8905337. DOI: 10.1210/endrev/bnab030.

References

Sartori R, Sandri M . BMPs and the muscle-bone connection. Bone. 2015; 80:37-42. DOI: 10.1016/j.bone.2015.05.023. View

Loffredo F, Steinhauser M, Jay S, Gannon J, Pancoast J, Yalamanchi P . Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013; 153(4):828-39. PMC: 3677132. DOI: 10.1016/j.cell.2013.04.015. View

Zhang Y, Shao J, Wang Z, Yang T, Liu S, Liu Y . Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma. Gene. 2014; 557(2):209-14. DOI: 10.1016/j.gene.2014.12.039. View

Katsimpardi L, Litterman N, Schein P, Miller C, Loffredo F, Wojtkiewicz G . Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science. 2014; 344(6184):630-4. PMC: 4123747. DOI: 10.1126/science.1251141. View

Hamrick M, Arounleut P, Kellum E, Cain M, Immel D, Liang L . Recombinant myostatin (GDF-8) propeptide enhances the repair and regeneration of both muscle and bone in a model of deep penetrant musculoskeletal injury. J Trauma. 2010; 69(3):579-83. PMC: 3738012. DOI: 10.1097/TA.0b013e3181c451f4. View

Li C, Cheng P, Liang M, Chen Y, Lu Q, Wang J . MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J Clin Invest. 2015; 125(4):1509-22. PMC: 4396470. DOI: 10.1172/JCI77716. View

Egerman M, Cadena S, Gilbert J, Meyer A, Nelson H, Swalley S . GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. Cell Metab. 2015; 22(1):164-74. PMC: 4497834. DOI: 10.1016/j.cmet.2015.05.010. View

Sinha M, Jang Y, Oh J, Khong D, Wu E, Manohar R . Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science. 2014; 344(6184):649-52. PMC: 4104429. DOI: 10.1126/science.1251152. View

Hamrick M, Shi X, Zhang W, Pennington C, Thakore H, Haque M . Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. Bone. 2007; 40(6):1544-53. PMC: 2001954. DOI: 10.1016/j.bone.2007.02.012. View

10.

Li H, Xie H, Liu W, Hu R, Huang B, Tan Y . A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest. 2009; 119(12):3666-77. PMC: 2786801. DOI: 10.1172/JCI39832. View

11.

Li Z, Kawasumi M, Zhao B, Moisyadi S, Yang J . Transgenic over-expression of growth differentiation factor 11 propeptide in skeleton results in transformation of the seventh cervical vertebra into a thoracic vertebra. Mol Reprod Dev. 2010; 77(11):990-7. PMC: 3099245. DOI: 10.1002/mrd.21252. View

12.

Wang D, Jiang T, Liao L, Huang J . Relationships between serum omentin-1 concentration and bone mineral density, and bone biochemical markers in Chinese women. Clin Chim Acta. 2013; 426:64-7. DOI: 10.1016/j.cca.2013.09.002. View

13.

Liu Z, Piao J, Pang L, Qing X, Nan S, Pan Z . The diagnostic criteria for primary osteoporosis and the incidence of osteoporosis in China. J Bone Miner Metab. 2002; 20(4):181-9. DOI: 10.1007/s007740200026. View

14.

Harvey N, Dennison E, Cooper C . Osteoporosis: a lifecourse approach. J Bone Miner Res. 2014; 29(9):1917-25. DOI: 10.1002/jbmr.2286. View

15.

Guo L, Jiang T, Liao L, Liu H, He H . Relationship between serum omentin-1 level and bone mineral density in girls with anorexia nervosa. J Endocrinol Invest. 2012; 36(3):190-4. DOI: 10.3275/8458. View

16.

Wu M, Hill C . Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell. 2009; 16(3):329-43. DOI: 10.1016/j.devcel.2009.02.012. View

17.

Hamrick M, McPherron A, Lovejoy C . Bone mineral content and density in the humerus of adult myostatin-deficient mice. Calcif Tissue Int. 2002; 71(1):63-8. DOI: 10.1007/s00223-001-1109-8. View

18.

McPherron A, Lawler A, Lee S . Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat Genet. 1999; 22(3):260-4. DOI: 10.1038/10320. View

19.

Wharton K, Derynck R . TGFbeta family signaling: novel insights in development and disease. Development. 2009; 136(22):3691-7. DOI: 10.1242/dev.040584. View

20.

Hamrick M . Increased bone mineral density in the femora of GDF8 knockout mice. Anat Rec A Discov Mol Cell Evol Biol. 2003; 272(1):388-91. DOI: 10.1002/ar.a.10044. View